Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

GC-BC-01, GC-BC-02, GC-BC-03 BICARBONATE DRY PACKS

K-Number: K901472 · 1990-07-27

ApplicantGranite Chemical Co., Inc.
Decision Date1990-07-27
Product CodeKPO
Advisory CommitteeGU
DecisionSubstantially Equivalent

Device Summary

GC-BC-01, GC-BC-02, GC-BC-03 BICARBONATE DRY PACKS is the device name listed in this FDA 510(k) record. The listed applicant is Granite Chemical Co., Inc.. It received FDA 510(k) clearance on 1990-07-27 under 510(k) number K901472. The device is classified under product code KPO. It was reviewed by the GU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the GC-BC-01, GC-BC-02, GC-BC-03 BICARBONATE DRY PACKS?

GC-BC-01, GC-BC-02, GC-BC-03 BICARBONATE DRY PACKS is a medical device that received FDA 510(k) clearance on 1990-07-27. The listed applicant is Granite Chemical Co., Inc.. The 510(k) number is K901472.

When did GC-BC-01, GC-BC-02, GC-BC-03 BICARBONATE DRY PACKS receive FDA 510(k) clearance?

GC-BC-01, GC-BC-02, GC-BC-03 BICARBONATE DRY PACKS received FDA 510(k) clearance on 1990-07-27, under 510(k) number K901472.

Who is the listed applicant for GC-BC-01, GC-BC-02, GC-BC-03 BICARBONATE DRY PACKS?

The FDA 510(k) record lists Granite Chemical Co., Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for GC-BC-01, GC-BC-02, GC-BC-03 BICARBONATE DRY PACKS?

The FDA product code for GC-BC-01, GC-BC-02, GC-BC-03 BICARBONATE DRY PACKS is KPO.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Granite Chemical Co., Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K901471GC-1000 THROUGH GC-3005 ACID CONCENTRATEK901473GC-01 THROUGH GC-99 ACETATE CONCENTRATE

Related Devices (Code: KPO)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K260799Nipro Dry Acid Concentrate MixerNipro Technical Solutions, IncoporatedK253462NaturaLyte® Dry Bicarbonate Concentrate (08-4112-2)Fresenius Medical Care Renal Therapies Group, LLCK252180Bicarby Dialysate RFP-404 (RFP-404-W); Bicarby Dialysate RFP-403 (RFP-403-W); Bicarby Dialysate RFP-403 (RFP-403-G); Bicarby Dialysate RFP-453 (RFP-453-W); Bicarby Dialysate RFP-453 (RFP-453-G); Bicarby Dialysate RFP-454 (RFP-454-W); Bicarby Dialysate RFP-454 (RFP-454-G); Bicarby Dialysate RFP-456 (RFP-456-W)Fresenius Medical Care Renal Therapies Group, LLCK243786Bicarby Dialysate RFP-402 (RFP-402-G); Bicarby Dialysate RFP-400 (RFP-400-G); Bicarby Dialysate RFP-407 (RFP-407-G); Bicarby Dialysate RFP-401 (RFP-401-G); Bicarby Dialysate RFP-404 (RFP-404-G); Bicarby Dialysate RFP-456 (RFP-456-G); Ci-Ca Dialysate 2K (RFP-457-G); Ci-Ca Dialysate 4K (RFP-458-G)Fresenius Medical Care Renal Therapies Group, LLCK240920HemoCare Bicarbonate Concentrate Set (BCS)Deka Research and DevelopmentK233950pureFLOW 402 (F00012067); pureFLOW 406 (F00012068); pureFLOW 401 (F00012069); pureFLOW 400 (F00012070)Fresenius Medical Care Renal Therapies Group, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑